Organon & Co.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.30
Forward P/E Ratio
3.63
PEG Ratio
0.23
6.87
Price-to-Sales (TTM)
0.57
3.87
3.44
Market Cap
3.50B
10.95B
Is it profitable?
Net Profit Margin (TTM)
3.99%
Gross Profit Margin
53.63%
Diluted EPS (TTM)
0.93
34.05%
6.16B
Is it growing?
-3.50%
67.80%
Is it risky?
1.55
948.95
1.97
8.57B
Who owns it?
76.17%
0.39%
8.06%
262.65M
261.00M
Does it pay?
0.60%
8.60%
Nov 14, 2024
Dec 12, 2024
How much cash?
1.12B
850.00M
529.12M
4.25
- Price
- 13.34
- Percent Change
- +0.03 (0.23%)
- Previous Close
- 13.31
- Open
- 13.32
- Low
- 13.30
- High
- 13.35
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$13.34
From 52W Low
+134.45%
From 52W High
-0.74%
Today
+0.23%
1Y Change
+65.92%
6M
$7.53
3M
$7.28
1M
$8.70
Today
$13.34
From 52W Low
+134.45%
From 52W High
-0.74%
Today
+0.23%
1Y Change
+65.92%
6M
$7.53
3M
$7.28
1M
$8.70
Today
$13.34
Expensive
within its 1-year price range
$13.34
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+53.3%
3M
+83.2%
6M
+77.2%
1Y
+65.9%
Rate of Change (ROC)
Accelerating
Price is rising 3.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Organon & Co.
- Founded
- 1923
- CEO
- Kevin Ali
- Employees
- 10,000
- Fiscal Year End
- Dec 31, 2024
- Address
30 Hudson Street
Jersey City
New Jersey
07302
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.organon.com
Indicators
Operating Cash Flow
850.00M
Net Income
246.00M
Real Earnings
3.46
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
850.00M
Net Income
246.00M
Real Earnings
3.46
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.30
Forward P/E Ratio
3.63
PEG Ratio
0.23
6.87
Price-to-Sales (TTM)
0.57
3.87
3.44
Market Cap
3.50B
10.95B
Is it profitable?
Net Profit Margin (TTM)
3.99%
Gross Profit Margin
53.63%
Diluted EPS (TTM)
0.93
34.05%
6.16B
Is it growing?
-3.50%
67.80%
Is it risky?
1.55
948.95
1.97
8.57B
Who owns it?
76.17%
0.39%
8.06%
262.65M
261.00M
Does it pay?
0.60%
8.60%
Nov 14, 2024
Dec 12, 2024
How much cash?
1.12B
850.00M
529.12M
4.25
- Price
- 13.34
- Percent Change
- +0.03 (0.23%)
- Previous Close
- 13.31
- Open
- 13.32
- Low
- 13.30
- High
- 13.35
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$13.34
From 52W Low
+134.45%
From 52W High
-0.74%
Today
+0.23%
1Y Change
+65.92%
6M
$7.53
3M
$7.28
1M
$8.70
Today
$13.34
From 52W Low
+134.45%
From 52W High
-0.74%
Today
+0.23%
1Y Change
+65.92%
6M
$7.53
3M
$7.28
1M
$8.70
Today
$13.34
Expensive
within its 1-year price range
$13.34
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+53.3%
3M
+83.2%
6M
+77.2%
1Y
+65.9%
Rate of Change (ROC)
Accelerating
Price is rising 3.5x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Organon & Co.
- Founded
- 1923
- CEO
- Kevin Ali
- Employees
- 10,000
- Fiscal Year End
- Dec 31, 2024
- Address
30 Hudson Street
Jersey City
New Jersey
07302
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.organon.com